sur INVENTIVA (EPA:IVA)
Inventiva Releases First Quarter 2024 Financial Results and Business Updates
Inventiva revealed its cash position as of March 31, 2024, with €11 million in cash, €0.1 million in short-term deposits, and €19.1 million in long-term deposits. In December 2023, these amounts were respectively 26.9 million, 0.01 million and 9 million euros.
The company consumed 29.4 million euros in operational activities in the first quarter of 2024, compared to 20.4 million for the same period in 2023. Operational financing reached 23.7 million euros thanks to an EIB loan . Inventiva expects to be able to finance its activities until the beginning of the third quarter of 2024.
Clinically, phase III of their NATiV3 trial continues without modification, with patient recruitment restarted in 15 countries. The first visit of the last patient is planned for the first half of 2024.
R. P.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de INVENTIVA